1.Jemperli (dostarlimab) plus chemotherapy receives positive CHMP opinion to expand approval to all adult patients with primary advanced or recurrent endometrial cancer.2.https://my.clevelandclinic.org/health/diseases/16409-uterine-cancer.3.子宫内膜癌诊治指南(2022 年版).我知道你在看哟↓↓↓